Well done, Payal Soni. Elevates the conversation.

Just out in JAMA Oncology: led by Daniel E Spratt & colleagues from UMich Rad Onc & Michigan Biostatistics — largest study of its kind finds societal factors & access to quality care, not genetics, underlies higher prostate cancer mortality rates among black men: michmed.org/Ex904

.U.S. News & World Report reports on the new JAMA Oncology racial disparities study from Robert Dess @Beam_Doc Holly Hartman, PhD Daniel E Spratt & team #pcsm usnews.com/news/healthies…

Black men not at higher risk of dying from prostate cancer, study finds Nice feature on NBCnews ⁦U-M Rogel Cancer Center⁩ ⁦@Beam_Doc⁩ ⁦Robert Dess⁩ nbcnews.com/health/mens-he…

Important point: we highlight both what IS (clear health inequity at a population level) and what CAN be (equal outcomes with equitable care). Despite the achievable, still much to be achieved. nbcnews.com/health/mens-he…

New JAMA Oncology study finds race not a factor in higher rates of dying from #prostatecancer in black men when there is equal access to care. ms.spr.ly/6018Ty2yC #PCSM

#STAMPEDEtrial shows that prostate radiotherapy improves survival for men with low burden metastatic #ProstateCancer but not high burden. Watch our animated abstract to learn more: bit.ly/2uQ5inL Nick James also on @Prof-Nick-James.bsky.social Chris Parker Matt Sydes ProstateUK Profs Prostate Cancer UK

Robert Dess giving one of the most important abstracts ASTRO. Great work! New staging system for PCa coming #ASTRO19

#ASTRO19 plenary session starts with Daniel E Spratt UMich Rad Onc U-M Rogel Cancer Center PreRT PSA predictive bio marker of benefit of ADT. No clear benefit of ADT in low PSA (<0.6). Higher cardiac and neuro toxicity with ADT. Great work by the team! Robert Dess Felix Feng Howard Sandler

Proudly retweeting from last year. #WomenWhoCurie also #MothersWhoCurie :)

Treatment of prostate cancer during #COVID19 in as few words as possible via ASTRO: astro.org/ASTRO/media/AS… #RadOnc #PCSM Robert Dess Daniel E Spratt Sean McBride Dr. Brandon Mahal Alison Tree 💙 Amar Kishan James Yu Prof Ananya💙 @achoud72.bsky.social

More good news from the UM team! Also online today is our JAMA Oncology paper on RTOG 9601. Huge congrats to Robert Dess Epic Will Jackson NRG Oncology Yilun Sun U-M Rogel Cancer Center UMich Rad Onc Wally Curran jamanetwork.com/journals/jamao…

Guidance on the management of prostate cancer patients during the #COVID19 pandemic. #AdvancesRO #RadOnc #PCSM bit.ly/2WMDMXw Nicholas Zaorsky, MD MS Robert Dess Daniel E Spratt Sean McBride Dr. Brandon Mahal Alison Tree 💙 Amar Kishan James Yu Prof Ananya💙 @achoud72.bsky.social UMich Rad Onc

Data from international collaborative cohort study w/19,684 men with non-metastatic #ProstateCancer were used to develop a novel clinical prognostic stage group system that outperformed existing AJCC system for prognosis ja.ma/37sVUeh #PCSM #GUCSM

Well said, Dr. Mallick.

📝Learn about #prostatecancer from diagnosis, management, side effects and cutting edge treatments available Michigan Medicine U-M Rogel Cancer Center If you missed it will be available at: 📺 youtube.com/c/MichiganMedi… 🙏🏽 Thankful for working with such a great team Robert Dess Megan Caram

Thank you U-Michigan Rad Onc Residents for this award. You have a bright future ahead. UMich Rad Onc was, is, and will continue to be a great place to train.

UMich Rad Onc is hiring! We have positions in both GU and Breast and are looking for enthusiastic candidates to apply and join an amazing team of clinicians, physicists, and biologists! #GoBlue. #theteam ARRO ASTRO ACRO - American College of Radiation Oncology

One of best parts of RadOnc is the collaborative team work moving the field forward. The power of physician-physicist partnerships can’t be understated. & while you don’t have to marry them for it to work, Robert Dess Kathryn Masi Dess Alex Price & I think it’s a solid method 🤣